The largest database of trusted experimental protocols

Signa hdx

Manufactured by Philips

The Signa HDX is a magnetic resonance imaging (MRI) system developed by Philips. It is designed to provide high-quality imaging for a range of medical applications. The core function of the Signa HDX is to generate detailed images of the body's internal structures using powerful magnetic fields and radio waves.

Automatically generated - may contain errors

2 protocols using signa hdx

1

Multi-site fMRI Preprocessing Workflow

Check if the same lab product or an alternative is used in the 5 most similar protocols
All subjects were scanned (eyes-open) by 3.0 Tesla scanners with different models, including Siemens TrioTim, GE Signa HDX, Philips, and Siemens Allegra. ADNI data were collected from 46 locations/sites, and B-SNIP data were collected from 6 sites. The imaging parameters of the two datasets are listed in Table 2.
The fMRI results underwent preprocessing through an SPM12 workflow that encompassed rigid body motion adjustment to rectify participant head movement, synchronization of slice timing, transformation to the standard MNI space utilizing the EPI template, resampling to isotropic voxels of (3mm)3, and smoothing via a Gaussian kernel (FWHM = 6mm). Quality assurance (QA) of the processed fMRI datasets involved eliminating images with low correlation to individual and/or group-level masks. Furthermore, fMRI data containing excessive head motion were removed to prevent possible erroneous variations in functional connectivity.
+ Open protocol
+ Expand
2

Multi-scanner, Contrast-enhanced Liver MRI Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Acquisitions from multiple MR imaging scanners with different contrast agents were used to allow for a more robust and generalizable machine learning model. Scanners were 1.5 T and 3 T models produced by Siemens (Aera, Avanto, Espree, TrioTim, Skyra, Verio), General Electric (SIGNA HDx), and Philips (Achieva). Studies were performed with several contrast agents, including Gadavist (Bayer), Magnevist (Bayer), Eovist (Bayer), Multihance (Bracco Diagnostics), Prohance (Bracco Diagnostics), Optimark (Covidien), and Dotarem (Guerbet). Contrast agents were administered at a dose of 1–1.5 mmol/kg with an injection speed of 2–5 mL/s. The input for our model consisted of multi-parametric, gadolinium-enhanced T1-weighted gradient echo acquisitions including arterial phase (35 s post-injection), portal venous phase (70 s post-injection), and delayed phase (3–5 min post-injection) imaging. Repetition and echo times ranged from 2.5–5.5 ms and 1–3 ms, respectively. Pixel bandwidth ranged from 250 to 650 Hz, pixel spacing from 0.5 to 1.7 mm, slice thickness from 3 to 5 mm, number of slices from 43 to 125, and image matrices from 160 × 160 to 415 × 200.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!